{"date":"2026-11-17","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6814-2026-11-17-1824-qahdms","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-11-17","time":"18:24:41","subject":"公告本公司肝癌之免疫細胞治療LuLym-T(Autologous Activated Lymphocytes;ATL)第二期人體臨床試驗期中分析結果","clause":"第44款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-11-17 18:24，「公告本公司肝癌之免疫細胞治療LuLym-T(Autologous Activated Lymphocytes;ATL)第」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-11-17-1806-142ih3h","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"18:06:31","subject":"公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」","clause":"第51款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-11-17 18:06，「公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-11-17-1806-1ozu4ay","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-11-17","time":"18:06:12","subject":"智擎公司公告將獲得再授權收入美金250萬元","clause":"第53款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-11-17 18:06，「智擎公司公告將獲得再授權收入美金250萬元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-11-17-1800-53eks2","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"18:00:06","subject":"代重要子公司永信藥品工業股份有限公司公告委外購物網站服務廠商發生資訊安全事件","clause":"第26款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-11-17 18:00，「代重要子公司永信藥品工業股份有限公司公告委外購物網站服務廠商發生資訊安全事件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-11-17-1759-ebkar0","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-11-17","time":"17:59:06","subject":"代子公司Double Harvest Inc.公告,向本公司取得AVITA (MAURITIUS) CORPORATION股權","clause":"第20款","fact_date":"2026-11-13","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-11-17 17:59，「代子公司Double Harvest Inc.公告,向本公司取得AVITA (MAURITIUS) CORPORATIO」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-11-17-1703-1nvflng","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-11-17","time":"17:03:03","subject":"公告本公司受邀參加台新證券舉辦之法說會","clause":"第30款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-11-17 17:03，「公告本公司受邀參加台新證券舉辦之法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-11-17-1652-s2hgke","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-11-17","time":"16:52:17","subject":"更正公告本公司取得境外子公司Double Harvest Inc普通股股權","clause":"第20款","fact_date":"2026-11-13","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-11-17 16:52，「更正公告本公司取得境外子公司Double Harvest Inc普通股股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-11-17-1651-13xguoc","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-11-17","time":"16:51:09","subject":"更正公告本公司處分境外子公司AVITA (MAURITIUS) CORPORATION 100%股權","clause":"第20款","fact_date":"2026-11-13","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-11-17 16:51，「更正公告本公司處分境外子公司AVITA (MAURITIUS) CORPORATION 100%股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-11-17-1649-19nh5oc","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-11-17","time":"16:49:43","subject":"本公司受邀參加華南永昌證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-11-26","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-11-17 16:49，「本公司受邀參加華南永昌證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-11-17-1600-3e8d45","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"16:00:19","subject":"公告本公司限制員工權利新股收足股款暨增資基準日","clause":"第51款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-11-17 16:00，「公告本公司限制員工權利新股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-11-17-1522-aqkmv1","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-11-17","time":"15:22:44","subject":"本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"第53款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-11-17 15:22，「本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-11-17-1336-l0uvpa","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"13:36:57","subject":"公告本公司115年第一次股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-11-17 13:36，「公告本公司115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-11-17-1336-12qa7co","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"13:36:36","subject":"本公司115年第一次股東臨時會決議解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-11-17 13:36，「本公司115年第一次股東臨時會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-11-17-1043-1fqkmsr","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-11-17","time":"10:43:08","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-11-17 10:43，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-11-17-1041-1fqkmsr","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"10:41:43","subject":"澄清媒體報導","clause":"第51款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-11-17 10:41，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-11-17-0935-1l09hoa","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-11-17","time":"09:35:53","subject":"公告本公司召開115年第二次法人說明會","clause":"第12款","fact_date":"2026-11-27","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-11-17 09:35，「公告本公司召開115年第二次法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}